Human medicine: approvals, safety communications and the trials and disclosures behind them.
The topics people around the world are reading most on Wikipedia right now, by field. Updated daily.
Global ranking: page views from every language edition of Wikipedia are added together, one day at a time. Top 5 in each field.
Wikipedia page views · Nov 5, 2026
Members can see the top 30, weekly trends and a ranking for each language.
Ranked by Wikipedia page views from human readers. Page views show how much attention a topic is getting, not its importance or accuracy. Source: Wikimedia Foundation (CC0).
Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call today at 2:00...
Reached alignment with the FDA on the final design of the ENABLE-2 pivotal Phase 3 trial On track to initiate ENABLE-2 before year-end 2026 Strong balance sheet with $884 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into 2030...
More than 50,000 doses of SKY-0515 have now been administered to patients. BOSTON, Nov. 5, 2026 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate RNA targets, today announced that the first U.S....
Confirmed rules and announcements from government bodies, regulators and official journals.
The Health Sciences Authority announced a Class 2 retail recall of AGELMIN TABLET 10 mg, batch 231871, manufactured by PHARMAKOE PTE LTD. The recall was initiated due to out-of-specification dissolution test results identified under the product quality surveillance programme.
The WHO recommended adding ChAdOx1 and Moderna’s mRNA-1469 to the Tumaini clinical trial in the Democratic Republic of the Congo. These vaccines are being evaluated against the Bundibugyo virus disease (Ebola), marking the first time this specific strain is targeted in this ongoing research.
Indonesia's BPOM is developing a new conditional approval regulation to accelerate market entry for vaccines and medicines without compromising safety standards. This regulatory innovation aims to bridge the vaccine gap by facilitating faster availability of critical products.
This page shows the three newest items per field. Members see every record in the field, in 109 languages, with the search engines that work on them.
Read it in full for $9No app-store installation. Cancel any time.
Every item links to the institution that published it. Nothing is rewritten without its source.
